

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.97875586 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.97875586 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.64152554 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64152554 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.32647533 |
| 6 | complement activation, alternative pathway (GO:0006957) | 5.90897682 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.78727930 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.78727930 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.78727930 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.77113264 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.54920678 |
| 12 | * regulation of protein activation cascade (GO:2000257) | 5.53024127 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.52273130 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.45740223 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.36152781 |
| 16 | urea metabolic process (GO:0019627) | 5.30854510 |
| 17 | urea cycle (GO:0000050) | 5.30854510 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.30249931 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.27555290 |
| 20 | * regulation of complement activation (GO:0030449) | 5.25508121 |
| 21 | epoxygenase P450 pathway (GO:0019373) | 5.21470416 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.17863794 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.15709008 |
| 24 | protein carboxylation (GO:0018214) | 5.15709008 |
| 25 | cysteine metabolic process (GO:0006534) | 5.13941931 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 5.06742712 |
| 27 | exogenous drug catabolic process (GO:0042738) | 5.04797635 |
| 28 | regulation of fibrinolysis (GO:0051917) | 5.02672798 |
| 29 | tyrosine metabolic process (GO:0006570) | 5.00743011 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.91063614 |
| 31 | regulation of plasminogen activation (GO:0010755) | 4.88565792 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81532321 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.81339312 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.78923030 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.74869331 |
| 36 | bile acid metabolic process (GO:0008206) | 4.74459302 |
| 37 | acute-phase response (GO:0006953) | 4.67531446 |
| 38 | protein-lipid complex assembly (GO:0065005) | 4.66827934 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.62041031 |
| 40 | intestinal cholesterol absorption (GO:0030299) | 4.61707595 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.58326454 |
| 42 | plasma lipoprotein particle clearance (GO:0034381) | 4.48296341 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.48265383 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.48265383 |
| 45 | negative regulation of hemostasis (GO:1900047) | 4.47555122 |
| 46 | negative regulation of blood coagulation (GO:0030195) | 4.47555122 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44184401 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.44184401 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.44184401 |
| 50 | omega-hydroxylase P450 pathway (GO:0097267) | 4.42741323 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.38263752 |
| 52 | protein-lipid complex subunit organization (GO:0071825) | 4.36255446 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.35849811 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.32213008 |
| 55 | lysine metabolic process (GO:0006553) | 4.31721130 |
| 56 | lysine catabolic process (GO:0006554) | 4.31721130 |
| 57 | phospholipid efflux (GO:0033700) | 4.25698039 |
| 58 | * regulation of humoral immune response (GO:0002920) | 4.19308780 |
| 59 | negative regulation of complement activation (GO:0045916) | 4.16047201 |
| 60 | cellular glucuronidation (GO:0052695) | 4.14103520 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.13700402 |
| 62 | negative regulation of coagulation (GO:0050819) | 4.13519626 |
| 63 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.10835201 |
| 64 | positive regulation of blood coagulation (GO:0030194) | 4.10043640 |
| 65 | positive regulation of hemostasis (GO:1900048) | 4.10043640 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.08285153 |
| 67 | amine catabolic process (GO:0009310) | 4.02296943 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.02296943 |
| 69 | negative regulation of cholesterol transport (GO:0032375) | 4.01808644 |
| 70 | negative regulation of sterol transport (GO:0032372) | 4.01808644 |
| 71 | coenzyme catabolic process (GO:0009109) | 4.01554246 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.01540394 |
| 73 | negative regulation of protein activation cascade (GO:2000258) | 4.01484980 |
| 74 | opsonization (GO:0008228) | 3.96085489 |
| 75 | cholesterol efflux (GO:0033344) | 3.94486244 |
| 76 | glycine metabolic process (GO:0006544) | 3.94306386 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 3.94065791 |
| 78 | ethanol oxidation (GO:0006069) | 3.93298147 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 3.90630950 |
| 80 | fibrinolysis (GO:0042730) | 3.90461815 |
| 81 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.88923973 |
| 82 | negative regulation of wound healing (GO:0061045) | 3.88741725 |
| 83 | imidazole-containing compound metabolic process (GO:0052803) | 3.88463889 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 3.85449600 |
| 85 | lipoprotein metabolic process (GO:0042157) | 3.85406057 |
| 86 | positive regulation of coagulation (GO:0050820) | 3.84101352 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.82548764 |
| 88 | * complement activation (GO:0006956) | 3.81647551 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 3.79111250 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 3.78589607 |
| 91 | cytolysis (GO:0019835) | 3.76867534 |
| 92 | glutamate metabolic process (GO:0006536) | 3.76634792 |
| 93 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.75330766 |
| 94 | * regulation of apoptotic cell clearance (GO:2000425) | 3.75111302 |
| 95 | * protein activation cascade (GO:0072376) | 3.71225556 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.71128186 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.71128186 |
| 98 | * complement activation, classical pathway (GO:0006958) | 3.70347032 |
| 99 | ethanol metabolic process (GO:0006067) | 3.70180116 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69756579 |
| 101 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68554752 |
| 102 | ketone body metabolic process (GO:1902224) | 3.66938649 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.66571000 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.65793137 |
| 105 | drug metabolic process (GO:0017144) | 3.65578206 |
| 106 | acetyl-CoA metabolic process (GO:0006084) | 3.64746776 |
| 107 | arginine metabolic process (GO:0006525) | 3.62489666 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.60801233 |
| 109 | intestinal absorption (GO:0050892) | 3.58976657 |
| 110 | aldehyde catabolic process (GO:0046185) | 3.58901076 |
| 111 | drug catabolic process (GO:0042737) | 3.58822473 |
| 112 | organic acid catabolic process (GO:0016054) | 3.58136418 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.58136418 |
| 114 | serine family amino acid biosynthetic process (GO:0009070) | 3.57592088 |
| 115 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56451781 |
| 116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56451781 |
| 117 | sterol homeostasis (GO:0055092) | 3.55086706 |
| 118 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.55035121 |
| 119 | negative regulation of lipase activity (GO:0060192) | 3.54782790 |
| 120 | valine metabolic process (GO:0006573) | 3.54752476 |
| 121 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.54001125 |
| 122 | regulation of bile acid biosynthetic process (GO:0070857) | 3.52493011 |
| 123 | acute inflammatory response (GO:0002526) | 3.51956291 |
| 124 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.49656842 |
| 125 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.49596742 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.48449408 |
| 127 | cofactor catabolic process (GO:0051187) | 3.47269299 |
| 128 | cholesterol transport (GO:0030301) | 3.41342927 |
| 129 | sterol transport (GO:0015918) | 3.41342927 |
| 130 | negative regulation of humoral immune response (GO:0002921) | 3.32997816 |
| 131 | regulation of cholesterol homeostasis (GO:2000188) | 3.26955545 |
| 132 | positive regulation of extracellular matrix organization (GO:1903055) | 3.09906181 |
| 133 | * regulation of acute inflammatory response (GO:0002673) | 3.08752706 |
| 134 | diacylglycerol metabolic process (GO:0046339) | 3.06727251 |
| 135 | positive regulation of steroid metabolic process (GO:0045940) | 3.03768808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.86279058 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.73280761 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.65440000 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.20085632 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.94743860 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.03032956 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.73169807 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.82597662 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.67719310 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.45374465 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16346284 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.09706744 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1018953 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92614911 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87240176 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79161407 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68861741 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52793966 |
| 19 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52530306 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48967755 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40558316 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39102239 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39082594 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38179801 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35678955 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33303032 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32817076 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31132555 |
| 29 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30652084 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27572478 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21549048 |
| 32 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13920074 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12860606 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08146828 |
| 35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02506302 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98750804 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97251793 |
| 38 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97216511 |
| 39 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97209588 |
| 40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95109819 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94692178 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94350454 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92556968 |
| 44 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91816713 |
| 45 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90923316 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90901352 |
| 47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88451183 |
| 48 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88331562 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88061171 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87848687 |
| 51 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87270641 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84948306 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83168091 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82818594 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81811519 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81334177 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81301163 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81301163 |
| 59 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80399792 |
| 60 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78781341 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78408081 |
| 62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78322379 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76865747 |
| 64 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.76314404 |
| 65 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.75868843 |
| 66 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75377208 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74935794 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74862033 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74841295 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73851784 |
| 71 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.73833763 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71918186 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71539355 |
| 74 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.71376763 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71008355 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70256384 |
| 77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69273081 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68951577 |
| 79 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66569953 |
| 80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66398248 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65972652 |
| 82 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65295739 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65271383 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.64717077 |
| 85 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64624286 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64434734 |
| 87 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64385242 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64106785 |
| 89 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.63363866 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.60858933 |
| 91 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.60795156 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60534111 |
| 93 | SA1_27219007_Chip-Seq_Bcells_Human | 0.60139829 |
| 94 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60043157 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59377508 |
| 96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.58880196 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58444127 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.57963059 |
| 99 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.57937887 |
| 100 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.56858255 |
| 101 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56673100 |
| 102 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56156447 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55413332 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55084145 |
| 105 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.54690408 |
| 106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54387369 |
| 107 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.52802102 |
| 108 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52239241 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50974239 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.50540167 |
| 111 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47497618 |
| 112 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.47451360 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.47168386 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46959718 |
| 115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.46136828 |
| 116 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45907826 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.45677968 |
| 118 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45665647 |
| 119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.45642102 |
| 120 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45501354 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45038917 |
| 122 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44678024 |
| 123 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44603054 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.43747713 |
| 125 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.43457870 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42821440 |
| 127 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.42417869 |
| 128 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.42320468 |
| 129 | CJUN_26792858_Chip-Seq_BT549_Human | 0.42046028 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41448771 |
| 131 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.41004093 |
| 132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.40664496 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.40664496 |
| 134 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40652612 |
| 135 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40488650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.65443527 |
| 2 | MP0005360_urolithiasis | 7.16152634 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.87221541 |
| 4 | MP0005365_abnormal_bile_salt | 5.79580508 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.67444709 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.69892065 |
| 7 | MP0003252_abnormal_bile_duct | 3.67170177 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.61937430 |
| 9 | MP0009840_abnormal_foam_cell | 3.04565455 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.74816181 |
| 11 | MP0005332_abnormal_amino_acid | 2.68614085 |
| 12 | MP0005083_abnormal_biliary_tract | 2.60940239 |
| 13 | MP0003195_calcinosis | 2.57186789 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.42897915 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.24935363 |
| 16 | MP0000609_abnormal_liver_physiology | 2.18260116 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.15984694 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.92832451 |
| 19 | MP0003172_abnormal_lysosome_physiology | 1.83367076 |
| 20 | MP0002254_reproductive_system_inflammat | 1.82605942 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.79934659 |
| 22 | MP0005670_abnormal_white_adipose | 1.79825982 |
| 23 | MP0001764_abnormal_homeostasis | 1.64869470 |
| 24 | MP0003868_abnormal_feces_composition | 1.58712670 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52894180 |
| 26 | MP0003303_peritoneal_inflammation | 1.52621988 |
| 27 | MP0003186_abnormal_redox_activity | 1.50333567 |
| 28 | MP0009785_altered_susceptibility_to | 1.49998226 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.42364361 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.38587788 |
| 31 | MP0009697_abnormal_copulation | 1.38191506 |
| 32 | MP0003122_maternal_imprinting | 1.31898705 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.31164317 |
| 34 | MP0003011_delayed_dark_adaptation | 1.30848866 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.29088390 |
| 36 | MP0005408_hypopigmentation | 1.27447857 |
| 37 | MP0005647_abnormal_sex_gland | 1.25542466 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.21794795 |
| 39 | MP0009764_decreased_sensitivity_to | 1.16701234 |
| 40 | MP0000598_abnormal_liver_morphology | 1.15580233 |
| 41 | MP0004130_abnormal_muscle_cell | 1.13545802 |
| 42 | MP0006054_spinal_hemorrhage | 1.10175539 |
| 43 | MP0005451_abnormal_body_composition | 1.09974737 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.07471402 |
| 45 | MP0005025_abnormal_response_to | 1.07334043 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.06783412 |
| 47 | MP0000604_amyloidosis | 1.05682909 |
| 48 | MP0009763_increased_sensitivity_to | 1.04547858 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.04206037 |
| 50 | MP0002419_abnormal_innate_immunity | 1.02325815 |
| 51 | MP0000685_abnormal_immune_system | 1.01178731 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 0.99004305 |
| 53 | MP0001661_extended_life_span | 0.97996868 |
| 54 | MP0001533_abnormal_skeleton_physiology | 0.97675637 |
| 55 | MP0005666_abnormal_adipose_tissue | 0.96573355 |
| 56 | MP0003879_abnormal_hair_cell | 0.96121853 |
| 57 | MP0002971_abnormal_brown_adipose | 0.95776446 |
| 58 | MP0008469_abnormal_protein_level | 0.95635513 |
| 59 | MP0001915_intracranial_hemorrhage | 0.94918453 |
| 60 | MP0005387_immune_system_phenotype | 0.94443211 |
| 61 | MP0001790_abnormal_immune_system | 0.94443211 |
| 62 | MP0005334_abnormal_fat_pad | 0.93010762 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 0.91651631 |
| 64 | MP0010155_abnormal_intestine_physiology | 0.90950004 |
| 65 | MP0003724_increased_susceptibility_to | 0.88807731 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.86334598 |
| 67 | MP0002089_abnormal_postnatal_growth/wei | 0.84774140 |
| 68 | MP0001756_abnormal_urination | 0.78897906 |
| 69 | MP0002933_joint_inflammation | 0.78817942 |
| 70 | MP0003690_abnormal_glial_cell | 0.78481767 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.77968655 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.76974273 |
| 73 | MP0001835_abnormal_antigen_presentation | 0.74274489 |
| 74 | MP0005535_abnormal_body_temperature | 0.73065012 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.71085056 |
| 76 | MP0000920_abnormal_myelination | 0.70365561 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.68525838 |
| 78 | MP0005275_abnormal_skin_tensile | 0.68312553 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.68022088 |
| 80 | MP0004381_abnormal_hair_follicle | 0.66974512 |
| 81 | MP0005084_abnormal_gallbladder_morpholo | 0.66887635 |
| 82 | MP0009115_abnormal_fat_cell | 0.66483115 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.65476920 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.64219687 |
| 85 | MP0002060_abnormal_skin_morphology | 0.63874448 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.63713555 |
| 87 | MP0000566_synostosis | 0.63322229 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.63205942 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.62610969 |
| 90 | MP0005448_abnormal_energy_balance | 0.62025205 |
| 91 | MP0005000_abnormal_immune_tolerance | 0.61466386 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.61400273 |
| 93 | MP0000858_altered_metastatic_potential | 0.60513548 |
| 94 | MP0009333_abnormal_splenocyte_physiolog | 0.60150876 |
| 95 | MP0003436_decreased_susceptibility_to | 0.60014650 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.58332377 |
| 97 | MP0005164_abnormal_response_to | 0.58219550 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.57606250 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.57187524 |
| 100 | MP0000343_altered_response_to | 0.56044486 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.55986398 |
| 102 | MP0001800_abnormal_humoral_immune | 0.55915795 |
| 103 | MP0005409_darkened_coat_color | 0.54266245 |
| 104 | MP0005671_abnormal_response_to | 0.52689711 |
| 105 | MP0001853_heart_inflammation | 0.51962593 |
| 106 | MP0004883_abnormal_blood_vessel | 0.51803669 |
| 107 | MP0002723_abnormal_immune_serum | 0.51639201 |
| 108 | MP0001881_abnormal_mammary_gland | 0.50823180 |
| 109 | MP0009053_abnormal_anal_canal | 0.50528172 |
| 110 | MP0000249_abnormal_blood_vessel | 0.49219109 |
| 111 | MP0002796_impaired_skin_barrier | 0.48808895 |
| 112 | MP0005395_other_phenotype | 0.48706242 |
| 113 | MP0005248_abnormal_Harderian_gland | 0.47682163 |
| 114 | MP0003632_abnormal_nervous_system | 0.47196478 |
| 115 | MP0002970_abnormal_white_adipose | 0.46801930 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.46797811 |
| 117 | MP0005266_abnormal_metabolism | 0.45029119 |
| 118 | MP0002168_other_aberrant_phenotype | 0.44913790 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.43291374 |
| 120 | MP0003953_abnormal_hormone_level | 0.43255235 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.43014910 |
| 122 | MP0002295_abnormal_pulmonary_circulatio | 0.41654006 |
| 123 | MP0003075_altered_response_to | 0.41549410 |
| 124 | MP0006082_CNS_inflammation | 0.40428983 |
| 125 | MP0005166_decreased_susceptibility_to | 0.40385279 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.39784795 |
| 127 | MP0001243_abnormal_dermal_layer | 0.38754792 |
| 128 | MP0003329_amyloid_beta_deposits | 0.37624266 |
| 129 | MP0000371_diluted_coat_color | 0.36998850 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.36950886 |
| 131 | MP0002928_abnormal_bile_duct | 0.36637532 |
| 132 | MP0005023_abnormal_wound_healing | 0.35593256 |
| 133 | MP0001324_abnormal_eye_pigmentation | 0.34848308 |
| 134 | MP0002132_abnormal_respiratory_system | 0.34717392 |
| 135 | MP0008873_increased_physiological_sensi | 0.33716051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.05203193 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.88739578 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.74090288 |
| 4 | Complement deficiency (HP:0004431) | 6.27415521 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.18721597 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.15186981 |
| 7 | Xanthomatosis (HP:0000991) | 6.13001766 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.62854150 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.28066473 |
| 10 | Joint hemorrhage (HP:0005261) | 4.65067700 |
| 11 | Abnormality of complement system (HP:0005339) | 4.60071132 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.57672155 |
| 13 | Epidermoid cyst (HP:0200040) | 4.49727258 |
| 14 | Hyperammonemia (HP:0001987) | 4.42224282 |
| 15 | Hyperglycinemia (HP:0002154) | 4.40474836 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.40469001 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.38229271 |
| 18 | Hyperglycinuria (HP:0003108) | 4.31471230 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.31182781 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.25646918 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.11528564 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 4.11528564 |
| 23 | Ketosis (HP:0001946) | 4.04972029 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.95458541 |
| 25 | Fat malabsorption (HP:0002630) | 3.90280764 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.82824572 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.79440991 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.69916198 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.69624929 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.62592769 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.50496476 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.48978856 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34028858 |
| 34 | Myocardial infarction (HP:0001658) | 3.27258372 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22654817 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.07304829 |
| 37 | Spontaneous abortion (HP:0005268) | 3.07216027 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05618656 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 3.01699382 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 2.94037578 |
| 41 | Steatorrhea (HP:0002570) | 2.93824722 |
| 42 | Ketoacidosis (HP:0001993) | 2.91986379 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.83938557 |
| 44 | Skin nodule (HP:0200036) | 2.82996094 |
| 45 | Delayed CNS myelination (HP:0002188) | 2.80065055 |
| 46 | * Systemic lupus erythematosus (HP:0002725) | 2.76317281 |
| 47 | * Purpura (HP:0000979) | 2.75167599 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.70150347 |
| 49 | Glomerulonephritis (HP:0000099) | 2.67825098 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.67352801 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.61261458 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61261458 |
| 53 | Metabolic acidosis (HP:0001942) | 2.58664536 |
| 54 | Vascular calcification (HP:0004934) | 2.57380097 |
| 55 | Amyloidosis (HP:0011034) | 2.57047157 |
| 56 | Pulmonary embolism (HP:0002204) | 2.56810415 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56523935 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56523935 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56523935 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.54266737 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52435337 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52435337 |
| 63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52435337 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.48153507 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47029865 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.47029865 |
| 67 | Lethargy (HP:0001254) | 2.45740821 |
| 68 | Hydroxyprolinuria (HP:0003080) | 2.43599346 |
| 69 | Abnormality of proline metabolism (HP:0010907) | 2.43599346 |
| 70 | Mitral stenosis (HP:0001718) | 2.41382016 |
| 71 | Gout (HP:0001997) | 2.41195800 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.38654894 |
| 73 | Spastic diplegia (HP:0001264) | 2.38114649 |
| 74 | Gingival bleeding (HP:0000225) | 2.37889979 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.35072386 |
| 76 | Hemorrhage of the eye (HP:0011885) | 2.34856914 |
| 77 | Pancreatitis (HP:0001733) | 2.34230618 |
| 78 | Esophageal varix (HP:0002040) | 2.29453227 |
| 79 | Acanthocytosis (HP:0001927) | 2.28546857 |
| 80 | Orchitis (HP:0100796) | 2.27442433 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.23400573 |
| 82 | Increased serum ferritin (HP:0003281) | 2.23348603 |
| 83 | Abnormal cartilage morphology (HP:0002763) | 2.21676328 |
| 84 | Hypertriglyceridemia (HP:0002155) | 2.19828931 |
| 85 | Neonatal onset (HP:0003623) | 2.19125654 |
| 86 | Optic neuritis (HP:0100653) | 2.18918956 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.18918956 |
| 88 | Generalized aminoaciduria (HP:0002909) | 2.18341196 |
| 89 | Cholelithiasis (HP:0001081) | 2.17165404 |
| 90 | Malnutrition (HP:0004395) | 2.16963784 |
| 91 | Irritability (HP:0000737) | 2.14774331 |
| 92 | Gangrene (HP:0100758) | 2.14456666 |
| 93 | Hypophosphatemic rickets (HP:0004912) | 2.14398830 |
| 94 | Nephritis (HP:0000123) | 2.13471520 |
| 95 | Cerebral edema (HP:0002181) | 2.12764550 |
| 96 | Enlarged kidneys (HP:0000105) | 2.09514762 |
| 97 | Menorrhagia (HP:0000132) | 2.08227823 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.05942297 |
| 99 | Vomiting (HP:0002013) | 2.05645295 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 2.04520372 |
| 101 | Cholecystitis (HP:0001082) | 2.04520372 |
| 102 | Thrombophlebitis (HP:0004418) | 2.03549579 |
| 103 | Joint swelling (HP:0001386) | 2.03448194 |
| 104 | Arthropathy (HP:0003040) | 2.01826783 |
| 105 | Epistaxis (HP:0000421) | 1.98830228 |
| 106 | Brushfield spots (HP:0001088) | 1.97960003 |
| 107 | Potter facies (HP:0002009) | 1.96695724 |
| 108 | Facial shape deformation (HP:0011334) | 1.96695724 |
| 109 | Opisthotonus (HP:0002179) | 1.92440860 |
| 110 | Osteomalacia (HP:0002749) | 1.90114385 |
| 111 | Nausea (HP:0002018) | 1.89430403 |
| 112 | Myositis (HP:0100614) | 1.88629316 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 1.88259848 |
| 114 | Proximal tubulopathy (HP:0000114) | 1.87507771 |
| 115 | Retinal atrophy (HP:0001105) | 1.87493145 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87155083 |
| 117 | Increased cerebral lipofuscin (HP:0011813) | 1.86943593 |
| 118 | Widely patent fontanelles and sutures (HP:0004492) | 1.85271127 |
| 119 | Renal cortical cysts (HP:0000803) | 1.84551888 |
| 120 | Alkalosis (HP:0001948) | 1.83367828 |
| 121 | Late onset (HP:0003584) | 1.82251303 |
| 122 | Abnormality of the gallbladder (HP:0005264) | 1.82134771 |
| 123 | Abnormality of the lumbar spine (HP:0100712) | 1.81895384 |
| 124 | Rickets (HP:0002748) | 1.81362102 |
| 125 | Abnormality of carpal bone ossification (HP:0006257) | 1.81341335 |
| 126 | Hyperuricemia (HP:0002149) | 1.79609494 |
| 127 | Increased purine levels (HP:0004368) | 1.79609494 |
| 128 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78856753 |
| 129 | Elevated hepatic transaminases (HP:0002910) | 1.77979118 |
| 130 | Hyperglycemia (HP:0003074) | 1.77000847 |
| 131 | Abnormal tarsal ossification (HP:0008369) | 1.74389062 |
| 132 | Metaphyseal irregularity (HP:0003025) | 1.71160116 |
| 133 | Abnormality of the Achilles tendon (HP:0005109) | 1.70258972 |
| 134 | Hypophosphatemia (HP:0002148) | 1.69973227 |
| 135 | Gastrointestinal infarctions (HP:0005244) | 1.65624451 |
| 136 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.64906833 |
| 137 | Abnormality of macrophages (HP:0004311) | 1.61804362 |
| 138 | Poikilocytosis (HP:0004447) | 1.59829504 |
| 139 | Peritonitis (HP:0002586) | 1.58136509 |
| 140 | Flat acetabular roof (HP:0003180) | 1.57314558 |
| 141 | Neurofibrillary tangles (HP:0002185) | 1.56607123 |
| 142 | Pigmentary retinal degeneration (HP:0001146) | 1.55085766 |
| 143 | Elevated alkaline phosphatase (HP:0003155) | 1.54618110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.90850278 |
| 2 | ERN1 | 4.46554030 |
| 3 | FGFR4 | 4.23471807 |
| 4 | SIK1 | 4.16165793 |
| 5 | MST1R | 3.94580592 |
| 6 | INSRR | 2.64968295 |
| 7 | TAOK3 | 2.57089583 |
| 8 | TRIB3 | 2.40237628 |
| 9 | ERBB4 | 2.28280643 |
| 10 | DDR2 | 2.23862229 |
| 11 | ICK | 2.20882874 |
| 12 | BLK | 1.97622388 |
| 13 | WNK4 | 1.97026594 |
| 14 | LATS1 | 1.88693586 |
| 15 | TYK2 | 1.82781115 |
| 16 | ACVR1B | 1.79036517 |
| 17 | MAPK11 | 1.69566748 |
| 18 | EPHA3 | 1.66272450 |
| 19 | TGFBR2 | 1.65388801 |
| 20 | CAMK1D | 1.64022178 |
| 21 | TIE1 | 1.61873952 |
| 22 | MATK | 1.59394209 |
| 23 | MET | 1.58900089 |
| 24 | PKN2 | 1.56341736 |
| 25 | PIK3CG | 1.52789179 |
| 26 | FRK | 1.51575289 |
| 27 | CDC42BPA | 1.51118065 |
| 28 | FGFR2 | 1.51088840 |
| 29 | TYRO3 | 1.50958647 |
| 30 | NEK9 | 1.49534382 |
| 31 | FLT3 | 1.46466963 |
| 32 | PTK6 | 1.40022466 |
| 33 | ABL2 | 1.39046923 |
| 34 | MAP2K4 | 1.38340980 |
| 35 | IRAK3 | 1.37300356 |
| 36 | MAP3K14 | 1.35113354 |
| 37 | FGR | 1.26677512 |
| 38 | JAK1 | 1.26434009 |
| 39 | PRKAA2 | 1.25370421 |
| 40 | GRK7 | 1.23305982 |
| 41 | MAP3K3 | 1.22138371 |
| 42 | MAP2K3 | 1.21117077 |
| 43 | TBK1 | 1.20765327 |
| 44 | JAK2 | 1.19941851 |
| 45 | EPHB1 | 1.18948484 |
| 46 | ZAP70 | 1.10081269 |
| 47 | FGFR3 | 1.09544601 |
| 48 | KDR | 1.05640692 |
| 49 | STK38L | 1.03964915 |
| 50 | MAP3K1 | 1.00820983 |
| 51 | ADRBK2 | 1.00433646 |
| 52 | PDK1 | 0.92154707 |
| 53 | SIK2 | 0.91792808 |
| 54 | MAPKAPK3 | 0.90430825 |
| 55 | RIPK1 | 0.90383828 |
| 56 | MYLK | 0.90344104 |
| 57 | MAP4K1 | 0.89336357 |
| 58 | CAMKK2 | 0.85582098 |
| 59 | PINK1 | 0.85259400 |
| 60 | GSK3A | 0.84962908 |
| 61 | DAPK2 | 0.84439020 |
| 62 | IKBKE | 0.83426580 |
| 63 | MAP3K7 | 0.82394090 |
| 64 | CDK6 | 0.81669135 |
| 65 | MAPK12 | 0.81477241 |
| 66 | CAMK1G | 0.80805883 |
| 67 | MAPK4 | 0.79855578 |
| 68 | BMX | 0.79594391 |
| 69 | TXK | 0.74845633 |
| 70 | ERBB2 | 0.74181053 |
| 71 | PDGFRA | 0.73406270 |
| 72 | MAP3K10 | 0.69276602 |
| 73 | CSK | 0.69076444 |
| 74 | PRKCZ | 0.67307529 |
| 75 | EPHB2 | 0.67195068 |
| 76 | MAP3K2 | 0.67072282 |
| 77 | LYN | 0.65784418 |
| 78 | PRKAA1 | 0.64622122 |
| 79 | SGK3 | 0.64132931 |
| 80 | SYK | 0.63147963 |
| 81 | PRKACG | 0.61671648 |
| 82 | PIM2 | 0.61454646 |
| 83 | WNK1 | 0.60857744 |
| 84 | TAOK1 | 0.59767575 |
| 85 | LCK | 0.58191390 |
| 86 | PDK3 | 0.56886024 |
| 87 | PDK4 | 0.56886024 |
| 88 | IGF1R | 0.56875353 |
| 89 | MAP3K6 | 0.54634777 |
| 90 | RIPK4 | 0.53630174 |
| 91 | MAPK15 | 0.53123954 |
| 92 | SGK2 | 0.52950889 |
| 93 | IRAK1 | 0.52495699 |
| 94 | PDPK1 | 0.51327751 |
| 95 | JAK3 | 0.50656253 |
| 96 | MAP2K1 | 0.50654024 |
| 97 | MAP3K5 | 0.50619036 |
| 98 | PRKG2 | 0.50301500 |
| 99 | CDK12 | 0.50177081 |
| 100 | PDK2 | 0.48575177 |
| 101 | CAMK2G | 0.46803782 |
| 102 | PTK2 | 0.46250976 |
| 103 | SRC | 0.46096491 |
| 104 | STK3 | 0.45732769 |
| 105 | FER | 0.45009302 |
| 106 | MAPK7 | 0.44407316 |
| 107 | IRAK4 | 0.44052141 |
| 108 | AKT3 | 0.43717389 |
| 109 | MAP2K6 | 0.43687019 |
| 110 | SGK1 | 0.41259017 |
| 111 | GRK1 | 0.40830816 |
| 112 | DYRK1B | 0.40702085 |
| 113 | GRK6 | 0.40275326 |
| 114 | ITK | 0.39174447 |
| 115 | PIK3CA | 0.36594803 |
| 116 | SGK223 | 0.35934035 |
| 117 | SGK494 | 0.35934035 |
| 118 | MAP2K2 | 0.35434475 |
| 119 | CSNK1G1 | 0.35368016 |
| 120 | MAP3K11 | 0.35033601 |
| 121 | PRKG1 | 0.33509540 |
| 122 | NUAK1 | 0.32546648 |
| 123 | CSF1R | 0.32509226 |
| 124 | ABL1 | 0.32283293 |
| 125 | MTOR | 0.31594964 |
| 126 | NLK | 0.31192332 |
| 127 | EPHA2 | 0.30478364 |
| 128 | MAP3K13 | 0.30158193 |
| 129 | PDGFRB | 0.29924618 |
| 130 | KIT | 0.29516150 |
| 131 | PRPF4B | 0.29195470 |
| 132 | CHUK | 0.29118454 |
| 133 | CDK4 | 0.29066307 |
| 134 | FGFR1 | 0.28828304 |
| 135 | TAOK2 | 0.28723672 |
| 136 | RET | 0.26292388 |
| 137 | EGFR | 0.26273206 |
| 138 | IKBKB | 0.25989106 |
| 139 | MAPK3 | 0.25466297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32473797 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.51805458 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17457857 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04995999 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89231559 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86770327 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67055533 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56111474 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50974678 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48629212 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47429057 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46523769 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27016032 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12766598 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11579116 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.10095037 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09446929 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01099776 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98190816 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96973386 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90614129 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90613337 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90149693 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88844312 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88191921 |
| 26 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86020336 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78527544 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67630691 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66648516 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66560938 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.64863638 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63653413 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55451408 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52749828 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48651140 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39993353 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39305695 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.38005786 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36956160 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31466756 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31423000 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28475808 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.24041233 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23065328 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16222889 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16135306 |
| 47 | * Pertussis_Homo sapiens_hsa05133 | 1.14408454 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13546549 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12135773 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08479832 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08348320 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07671143 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00777677 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97467198 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94723791 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94563820 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92381941 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85745424 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84956247 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84383298 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82060428 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81923931 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80551019 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.76219381 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.69835954 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.68034790 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64464553 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64422376 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63364575 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52599702 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.51090405 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46128255 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.45862008 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41948030 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41422755 |
| 76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40813552 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40371452 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38179171 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37227114 |
| 80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.35519413 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34744374 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33425082 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.31647600 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29030430 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.27824058 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27322086 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27089521 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26380569 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24644838 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.23033533 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20200688 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19259001 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.18742022 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18016769 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.17386009 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.15866961 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.15738351 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15321417 |
| 99 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.14468526 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.14176081 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12245569 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11525191 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08902124 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07060355 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03303727 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2029228 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1993376 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1969795 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1852397 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1592224 |
| 111 | Malaria_Homo sapiens_hsa05144 | -0.1431589 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1211187 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1203448 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1066361 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0994533 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | -0.0985837 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | -0.0981835 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0856254 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0772547 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0557604 |
| 121 | Lysosome_Homo sapiens_hsa04142 | -0.0542209 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0444217 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0110915 |

